White House Government Agencies

More

  • The flock in Dubois County, Indiana, was infected with a strain known as H7N8, which is different from strains that caused more than 48 million chickens and turkeys to die last year, according to the USDA. Indiana officials quarantined the farm with the infected turkeys and the birds are being killed to prevent the spread of the disease, the USDA said.

  • Jan 15- The U.S. Food and Drug Administration on Friday cleared Japan's Olympus Corp's duodenoscope with changes to the device's design and labeling, intended to help reduce the risk of bacterial infections. Physicians perform about 500,000 such procedures every year in the United States. Other companies that sell duodenoscopes in the United States include...

  • Jan 15- The U.S. Food and Drug Administration on Friday cleared Japan's Olympus Corp's duodenoscope with changes to the device's design and labeling intended to help reduce the risk of bacterial infections. Olympus will voluntarily recall its original model being used in health care facilities to fix them as quickly as possible, the regulator said.

  • The FDA report comes a day after the U.S. regulator rejected BioMarin Pharmaceutical Inc's rival drug Kyndrisa. There are no FDA- approved drugs for DMD, and pressure has been mounting on the U.S. regulator to quickly approve treatments. The FDA staff questioned the validity of the' small' study used by Sarepta to test its drug's efficacy, saying they considered the...

  • Jan 15- U.S. Food and Drug Administration staff said on Friday Sarepta Therapeutics Inc did not provide enough evidence to support the effectiveness of its drug to treat a rare muscle wasting disorder. Both drugs target a particular subset of DMD patients, which translates into an addressable population of about 1,800 boys in the United States and about 5,000...

  • Jan 15- U.S. Food and Drug Administration staff said on Friday Sarepta Therapeutics Inc did not provide enough evidence to support the effectiveness of its drug to treat a rare muscle wasting disorder. The drug, eteplirsen, is designed to treat a particular subset of Duchenne muscular dystrophy patients. Sarepta's shares plunged 40 percent in premarket...

  • MUMBAI, Jan 15- Indian drugmaker Wockhardt Ltd said the U.S. Food and Drug Administration had issued a notice outlining manufacturing violations at its Shendra plant in western India, delaying the company's plans to rebuild its battered U.S. business. In a so-called' Form 483' issued to the company after a recent inspection of the plant, the FDA listed nine...

  • Jan 15- Heron Therapeutics Inc said the U.S. Food and Drug Administration had postponed a decision on its injectable drug to treat chemotherapy-induced nausea. The FDA is now expected to decide on Sustol by late February instead of the earlier deadline of Sunday, Heron said on Friday. Chemotherapy-induced nausea and vomiting, considered one of the most acute...

  • Jan 15- Heron Therapeutics Inc said the U.S. Food and Drug Administration will delay a decision on its injectable drug to treat chemotherapy-induced nausea.

  • SAN FRANCISCO, Jan 14- Amazon.com Inc's China arm has registered as an ocean freight forwarder, according to the U.S. Federal Maritime Commission, a move that will give it more control over shipping products from Chinese factories to U.S. shoppers. Amazon is already negotiating a deal to lease 20 jets to start an air-delivery service in the United States, the...

  • SAN FRANCISCO, Jan 14- Online retailer Amazon.com Inc's China division has registered as an ocean freight forwarder, according to the U.S. Federal Maritime Commission, a move which allows it to coordinate cargo shipments between China and the United States. Amazon is already negotiating a deal to lease 20 jets to start its own air-delivery service in the United...

  • Jan 14- Online retailer Amazon.com Inc's China division has registered to provide ocean freight services, which allows it to coordinate shipments between China and the United States, according to a Federal Maritime Commission filing.

  • Jan 14- Online retailer Amazon.com Inc's China division has received a license to operate as an ocean freight forwarder in the United States, according to a Federal Maritime Commission filing.

  • Jan 14- Once again, rather than the Federal Reserve guiding expectations, it is the market calling the shots- this time in correctly expecting fewer and later rate rises. Even relative hawks and insiders like James Bullard, President of the St Louis Federal Reserve, are now expressing reservations about policy, less than a month after helping to push through the...

  • MEMPHIS, Jan 14- The continued rout on global oil markets has caused a "worrisome" drop in U.S. inflation expectations that may make further rate hikes hard to justify, St. Louis Federal Reserve President James Bullard said on Thursday. Since the dramatic fall in oil began in 2014 Fed officials have insisted the impact on U.S. price levels would be temporary,...

  • *Fourth-qtr EPS $1.32 vs. est. The bank- the first big lender to report results since the Federal Reserve raised its key interest rate in mid-December- said on Thursday it expected net interest income to rise by about $2 billion as a result of the hike and loan growth. The New York- based lender forecast incremental increases in the amount of money set aside for...

  • *Kyndrisa had received negative FDA review in Nov. The rejection caps months of uncertainty surrounding the drug, Kyndrisa, which was billed to be the first treatment in the United States for Duchenne muscular dystrophy. A panel of independent advisers to the FDA had in November indicated that Kyndrisa's effectiveness in trials was not enough to warrant...

  • NEW YORK, Jan 14- The dollar rose on Thursday, bolstered by gains in the U.S. stock market and a rebound in oil prices, suggesting that the Federal Reserve will not be as constrained to push ahead with its plan to raise interest rates several times this year. That has supported shares on Wall Street, with key indexes up more than 1 percent on the day.

  • Abused child

    The US spends $80 billion a year on child welfare services, but too much goes to outdated, inefficient models.

  • Jan 14- BioMarin Pharmaceutical Inc said on Thursday the U.S. Food and Drug Administration had rejected the company's drug to treat a rare muscle-wasting disorder. The rejection comes after a panel of independent advisers to the FDA indicated that efficacy data on the drug was not persuasive enough for an approval. There is currently no FDA- approved therapy to...